| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.065 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |